Citius Pharmaceuticals Inc vs Kaltura Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Kaltura Inc trades at $1.63 (market cap $249.42M). The key difference: Kaltura Inc is far larger — about 12.5× Citius Pharmaceuticals Inc's market cap, and Kaltura Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | KLTR | |
|---|---|---|
Market Cap | $20.01M | $249.42M |
Sector | Health | Technology |
52-Week High | $1.82 | $1.89 |
52-Week Low | $0.48 | $1.08 |
Enterprise Value | $16.23M | $261.64M |
Trailing returns across standard periods
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →